Abstract
The potential to use adult Artemia to deliver erythromycin to first‐feeding sockeye salmon, Oncorhynchus nerka (Walbaum), was investigated in three trials. In the first trial, first‐feeding sockeye were fed live erythromycin enriched adult Artemia or pellets containing equal amounts of erythromycin for 35 days. At the end of the trial, tissue erythromycin concentration of the fish fed the live Artemia was significantly greater ( P μ g mL −1 ; mean ± SEM), than the tissue concentration of the fish fed the pellets (0.72 ± 0.01 μ g mL −1 ). In the second trial, first‐feeding sockeye were fed either live or freeze‐dried bioencapsulated erythromycin (adult Artemia ) or pellets containing erythromycin daily for 21 days. Mean daily erythromycin concentration in fish fed the freeze‐dried Artemia , live Artemia , or pellets did not differ significantly. In the third trial, apparent erythromycin digestibility was determined. Significantly more ( P Artemia (live or freeze‐dried) appears to be greater than uptake from pellets. Freeze‐dried and live Artemia were equally effective at delivery suggesting enriched freeze‐dried adult Artemia could be produced into a highly palatable, consistent, off‐the‐shelf product.